IDEXX Laboratories, Inc.’s IDXX strong momentum in its CAG (Companion Animal Group) Diagnostics business places it well for growth in the upcoming quarters. It is also building its global commercial ...
IDEXX's IDXX strong execution of strategic priorities are a key growth factor. Enhancing global commercial capability will sustain CAG Diagnostics’ recurring revenue growth. Yet, currency impacts and ...
IDEXX Laboratories IDXX has shown remarkable momentum so far this year, climbing 52.9%. The stock has comfortably surpassed the industry’s 12.9% fall and the S&P 500 Composite’s 13.8% gain. Carrying a ...
IDEXX Laboratories, Inc. IDXX recently acquired New Zealand-based ezyVet to expand its cloud-based practice information management system (PIMS) offerings. IDEXX’s three core PIMS offerings, including ...
IDEXX LaboratoriesIDXX has shown remarkable momentum so far this year, climbing 75.6%. The stock outperformed the industry’s 4.2% rise and the S&P 500 composite’s 18.5% gain. Carrying a Zacks Rank #3 ...
IDEXX Laboratories, Inc.’s IDXX consistent strong performance of the CAG (Companion Animal Group) segment is poised to help it grow in the upcoming quarters. Robust demand for its cloud-based ...
IDEXX Laboratories, Inc. IDXX is well-poised to grow in the upcoming quarters due to the performance of its CAG (Companion Animal Group) Diagnostics business. The consistent growth in international ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback